Praxis Precision Medicines (PRAX) Return on Capital Employed (2020 - 2026)

Praxis Precision Medicines' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 31.1% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 2168.0% year-over-year to 31.1%; the TTM figure through Mar 2026 stood at 31.1% (up 2168.0% YoY), while the FY2025 annual figure was 50.13%, up 3059.0% from the prior year.
• Return on Capital Employed was 31.1% for Q1 2026 at Praxis Precision Medicines, up from 53.71% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 31.1% in Q1 2026 to a low of 239.76% in Q1 2023.
• Historically, Return on Capital Employed has averaged 108.61% across 5 years, with a median of 86.56% in 2024.
• The sharpest annual moves came in 2022 and 2024: Return on Capital Employed plunged 17258 bps in 2022, then surged 15320 bps in 2024.
• A 5-year view of Return on Capital Employed shows it stood at 234.52% in 2022, then surged by 34 bps to 154.89% in 2023, then surged by 69 bps to 48.57% in 2024, then dropped by 11 bps to 53.71% in 2025, then surged by 42 bps to 31.1% in 2026.
• The last three Return on Capital Employed figures came in at 31.1% (Q1 2026), 53.71% (Q4 2025), and 78.85% (Q3 2025), per Business Quant data.